...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

,,,incredible,,,,,,sell pressure is increasing on this so called good news,,,,,,,,,what else would we expect!!,,,,,,more likely this news will send us below our closing price from last evening. Nothing is changing other than an increase in the disrespect the investing world has for this stock and the management team behind it!

 

Share
New Message
Please login to post a reply